SCHEMBL19868925

SCHEMBL19868925

Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK11 Q15759 17/20 1.00
MAPK14 Q16539 17/20 1.00
MAPK13 O15264 16/20 1.00
MAPK12 P53778 16/20 1.00
GCGR P47871 14/20 1.00
CSNK1A1 P48729 5/20 1.00
CSNK1D P48730 5/20 1.00
PRKD3 O94806 4/20 1.00
MAP4K4 O95819 4/20 1.00
FRK P42685 4/20 1.00
MAPK9 P45984 4/20 1.00
GSK3B P49841 4/20 1.00
CLK4 Q9HAZ1 3/20 1.00
PTK6 Q13882 3/20 1.00
PRKD2 Q9BZL6 3/20 1.00
ALOX5 P09917 13/20 0.88
ALDH1A1 P00352 4/20 0.86
PRKACA P17612 3/20 0.86
SLK Q9H2G2 3/20 0.86
RIPK2 O43353 3/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15075603 1.00 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2650702 0.94 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL9195042 0.94 MAPK14 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL4552316 0.94 MAPK14 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2649616 0.93 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-202190 SCHEMBL3386753 0.93 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL9195650 0.93 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2650684 0.93 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2648930 0.93 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL6469126 0.93 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS CREB1, PPP6R1, PPP1R10 MAPK11 903/4885MAPK14 440/4885MAPK13 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.